TABLE 3.
Comparison of MPRs and PDCs in Studies Comparing Mail and Retail Pharmacies.
| Disease State | Group | Differences | ||
|---|---|---|---|---|
| Mail-Order Group (%) | Retail Group (%) | Difference (% points) | ||
| Asthma | Visaria et al.20,a | 62.4 | 39.7 | 22.7b |
| Khandelwal et al.15,a | 68.1 | 67.2 | 0.9 | |
| Hypertension | Khandelwal et al.15,a | 79.0 | 79.0 | 0.0 |
| Duru et al.27,c | 88.1 | 80.4 | 7.7b | |
| Cholesterol | White et el.25,a | 92.6 | 82.5 | 10.1b |
| Khandelwal et al.15,a | 77.6 | 76.7 | 0.9 | |
| Duru et al.27,c | 81.7 | 72.4 | 9.3b | |
| Diabetes | Duru et al.27,c | 81.8 | 75.2 | 6.6b |
| Devine et al.29,a,d | 84.8 | 63.4 | 21.4b | |
| Zhang et al.30,a | 68.0 | 61.0 | 7.0b | |
| Khandelwal et al.15,a | 83.1 | 80.2 | 2.9 | |
| Sharma et al.31,e | Not reported | Not reported | 8.6 | |
| Depression | Khandelwal et al.15,a | 72.3 | 71.5 | 0.8 |
| CHF, CAD | Khandelwal et al.15,a | 77.3 | 78.9 | 1.6 |
| Thyroid | Khandelwal et al.15,a | 80.2 | 80.8 | 0.6 |
| Other diseases | ||||
| Diuretics | Khandelwal et al.15,a | 75.4 | 73.9 | 1.5 |
| Calcium channel blockers | Khandelwal et al.15,a | 78.9 | 79.3 | 0.4 |
a Medication possession ratio.
b Statistically significant.
c Continuous measure of medication gaps (percentages of patients who were adherent, CMG ≤ 20%).
d Patients switched groups.
e Proportion of days covered.
CAD = coronary artery disease; CHF = congestive heart failure; CMG = continuous measure of medication gaps; MPR = medication possession ratio; PDC = proportion of days covered.